Diagnostic hapten-carrier conjugates BSA-dehydroepiandrosterone (DHEA), OVA-dehydroepiandrosterone (DHEA), KLH-dehydroepiandrosterone (DHEA) for Hormone disordersDHEA detection in Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT.
Product Details
Dehydroepiandrosterone (DHEA), also known as androstenolone, is an endogenous steroid hormone precursor. It is one of the most abundant circulating steroids in humans. DHEA is produced in the adrenal glands, the gonads, and the brain.It functions as a metabolic intermediate in the biosynthesis of the androgen and estrogen sex steroids both in the gonads and in various other tissues.Genemedi produces core diagnostic ingredients for test of Hormone disorders and related syndrome.
GeneMedi offers Diagnostic hapten-carrier conjugates BSA-dehydroepiandrosterone (DHEA), OVA-dehydroepiandrosterone (DHEA), KLH-dehydroepiandrosterone (DHEA) for Hormone disorders DHEA detection in Competitive immunoassay validation (Competitive ELISA), Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. All the antibodies and antigens for Hormone disorders test are suitable for in functional ELISA, and other immunoassays in dignostics.
Product Description
|
Cat No.
|
GMP-SMT-DHEA-Ag
|
|
Product Name
|
BSA-dehydroepiandrosterone (DHEA) / OVA-dehydroepiandrosterone (DHEA)
|
|
Expression platform
|
Synthetic
|
|
Bioactivity validation
|
dehydroepiandrosterone (DHEA) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in DHEA level test of Hormone disorders (Hormone disorders) and related syndrome evaluation
|
|
Products description
|
Competitive immunoassay-validated hapten-carrier conjugates BSA-dehydroepiandrosterone (DHEA) / OVA-dehydroepiandrosterone (DHEA) is Synthetic.
|
|
Purity
|
|
|
Application
|
Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
|
|
Formulation
|
Lyophilized from sterile PBS, PH 7.4
|
|
Storage
|
Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.
|
|
Cat No.
|
GMP-SMT-DHEA-Ag
|
|
Product Name
|
|
|
Expression platform
|
|
|
Isotypes
|
|
|
Bioactivity validation
|
|
|
Tag
|
|
|
Products description
|
|
|
Specics
|
|
|
Purity
|
|
|
Application
|
|
|
Formulation
|
|
|
Storage
|
|
Diagnostic antibodies and antigens for Epilepsy-related valproate (VPA) toxicity testing: Sodium valproate (VPA)
Valproate is a commonly used antiepileptic drug for the treatment of epilepsy and seizures. It is safe for use in both adults and children more than three years of age. Valproate toxicity can occur both accidentally and intentionally. Acute valproate overdose usually presents with CNS depression/encephalopathy, electrolyte abnormalities such as hypernatremia, elevated transaminase levels, hyperammonemia, and hepatoxicity. In patients with a severe overdose of valproate, patients can present with hypotension, tachycardia, respiratory depression, metabolic acidosis, cerebral edema, and valproate-related hyperammonemic encephalopathy which may progress to coma and death. GENEMEDI developed the Gastrin-17 (G-17) antigens and antibodies for the diagnosis of valproate toxicity based on ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
